Legal

Company Engagement Terms

These terms supplement the general Terms of Use for organizations that inquire about or pursue a Resident insight engagement through Resident Advisory Network. A separately accepted proposal or signed agreement controls if it conflicts with these terms.

Effective August 29, 2026

An inquiry is not an engagement. No services, Resident outreach, access, deliverables, or payment obligation begins solely because a Company submits an inquiry or creates an account.

1. Incorporation and authority

The Terms of Use and Privacy Policy are incorporated into these Company Engagement Terms. The person acting for a Company represents that they are authorized to submit information and accept applicable proposals or agreements on its behalf.

2. Concierge inquiry and qualification

RAN may evaluate project fit, request clarification, decline an inquiry, suggest changes, or invite the Company to create an account and submit a detailed project request. RAN does not guarantee that a project will be accepted, that any particular Resident will be available, or that a desired timeline, budget, sample, or outcome can be achieved.

3. Proposal and authorization

A project may proceed only after the required review and acceptance of a written scope or fixed proposal. Unless a controlling agreement says otherwise, a proposal should identify scope, participant profile, format, timing, Resident compensation, RAN fees, payment and cancellation terms, confidentiality, and intellectual-property terms. Material changes may require a revised proposal and renewed acceptance.

4. Permitted purpose and prohibited requests

Company requests must seek legitimate, predefined professional insight. The Company may not use RAN to request or obtain:

  • Patient care, patient-specific advice, protected health information, identifiable patient details, EHR content, or clinical-system access.
  • Confidential or proprietary institutional, employer, vendor, product, research, or third-party information the Resident is not authorized to disclose.
  • Influence over prescriptions, referrals, formularies, purchasing, protocols, utilization, or institutional business decisions.
  • Compensation contingent on sales, revenue, referrals, prescriptions, purchasing, utilization, investment performance, or other commercial outcomes.
  • Unapproved institutional branding, endorsement, recruiting, credentialing, clinical services, or activity that conflicts with training duties.

5. Screening is not approval

RAN may collect responses and apply Green, Yellow, Red, “reviewed,” or similar internal labels to support workflow triage. These labels and any RAN review are not legal opinions, compliance certification, institutional approval, or assurances that an activity satisfies every contract, policy, law, regulation, or professional obligation. The Company must conduct its own legal, regulatory, privacy, security, and institutional review.

6. Resident identity and contact

The Company will not attempt to identify, contact, recruit, or obtain non-public information about a Resident before RAN authorizes a connection. The Company will not use network information to bypass an accepted process or avoid agreed fees. After connection, the Company may use Resident information only for the authorized engagement and other purposes expressly agreed by the Resident.

7. Company materials and instructions

The Company represents that it has the right to provide all materials, prototypes, content, and instructions supplied for a project. The Company must identify applicable confidentiality, safety, regulatory, security, and use restrictions before work begins and must not direct a Resident to act outside the accepted scope or their professional role.

8. Deliverables and decisions

Resident feedback reflects individual perspectives and is not clinical, legal, regulatory, investment, or purchasing advice. The Company is solely responsible for product, research, investment, employment, regulatory, commercial, and patient-safety decisions. RAN does not guarantee accuracy, representativeness, adoption, performance, regulatory clearance, or commercial results.

9. Payment, cancellation, and taxes

Applicable pricing, deposits, invoices, refunds, cancellation charges, expenses, and payment timing must be stated in the accepted proposal or separate agreement. The Company is responsible for taxes imposed on its purchases except taxes based on RAN's net income. RAN may pause work or withhold a connection or deliverable for overdue amounts where permitted by the controlling agreement and law.

10. Contact

Company engagement questions may be sent to hello@residentadvisorynetwork.com.